Home » Regions » Global News » VitalTrax announces availability of clinical trial network Wing

VitalTrax announces availability of clinical trial network Wing

Friday, September 8, 2017

VitalTrax announced availability of Wing, a Clinical Trial Network, which gives patients, caregivers and physicians an OpenTable-like experience in finding and enrolling in clinical trials. It is a first of its kind solution that is optimized for patients’ experience. Wing contains information for over 55,000 clinical trials currently enrolling giving patients a single destination.

Wing provides trial sponsors and research sites the ability to publish and promote their trials so patients can easily find them. It also gives the research sites the tools to interact with and enroll patients. By addressing the unique needs of the entire eco system—patients, research sites and sponsors—Wing creates a seamless Clinical Trial Network that facilitates enrollment and participation of patients in clinical trials.

“VitalTrax team has decades of experience in building secure and compliant solutions for the pharmaceutical industry. Wing complies with the HIPAA and FDA regulations to ensure patient’s data is secure and shared with only the healthcare providers they chose. We have worked closely with patients and patient advocates to ensure the solution is easy to use and addresses patients’ needs” said, Todd Kueny, cofounder and CTO of VitalTrax.

“Finding a clinical trial in Wing is simple and easy. It also helps to manage the application process which can be a stressful and arduous process for patients. It meets a critical need for patients today who are looking to find the right clinical trial for them” said T.J. Sharpe, a cancer survivor and patient advocate who serves on the advisory board for VitalTrax.

“Our first and foremost objective is to create a great experience for patients and for that we work closely with patients and patient advocates to design our solution. Wing meets a critical need for patients—to find and enroll in clinical trials—efficiently. It also gives research sites and sponsors the ability to easily publish and promote their trials to encourage enrollment.” said Zikria Syed, cofounder and CEO of VitalTrax.

Related Posts